Trichotillomania: Clinical Presentation, Diagnosis, and Etiology

    January 2018 in “ Springer eBooks
    Giuseppe Micali, Anna Elisa Verzì, Federica Dall’Oglio, Francesco Lacarrubba
    Image of study
    TLDR Trichotillomania is a condition where people repeatedly pull out their hair, which can be triggered by stress and has various physical signs.
    Trichotillomania is characterized by hair loss resulting from the patient's repetitive self-pulling of hair, and while it has been traditionally associated with obsessive-compulsive disorder, it also shares similarities with tic disorders. The exact prevalence is unknown but estimated to be between 0.6% and 4.0%, with a study of 210 children showing a 7% prevalence among those with hair loss and scalp disorders. The etiology is complex, involving psychosocial issues and neurobiological factors, with about 50% of cases in a study of 33 patients having identifiable triggers such as appearance concerns, family or school issues, or concurrent illness. Clinically, trichotillomania presents as ill-defined patches of incomplete alopecia with broken hairs of varying lengths, sometimes accompanied by perifollicular erythema, hemorrhage, or excoriations. The scalp is the most common area affected, but eyelashes, eyebrows, and pubic hair can also be involved. Trichophagia, the ingestion of pulled hairs, occurs in about 5-30% of adult patients and can lead to trichobezoar, a rare complication. Differential diagnosis includes alopecia areata, tinea capitis, telogen effluvium, and traction alopecia. Diagnosis follows the DSM-5 criteria, which include recurrent hair pulling resulting in hair loss, attempts to stop the behavior, significant distress, and exclusion of other medical or mental conditions. Dermatoscopy reveals broken hairs, hair powders, and specific signs like flame hairs, coiled hairs, and tulip hairs. Histopathological examination typically shows increased catagen and telogen hairs without inflammation, pigment casts, empty anagen follicles, and torn-away follicles, sometimes with perifollicular hemorrhage.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    3 / 3 results

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Verteporfin day 119 update - donor hair regeneration human trial

      in Research/Science  146 upvotes 2 years ago
      A human trial of verteporfin, a drug that can inhibit wound healing by scarring and promote regeneration of original tissue and hair follicles to provide an unlimited source for hair transplants; people discussed the potential of this drug and how it could be rolled out in mainstream with more doctors getting on board.

    Similar Research

    5 / 1000+ results
      Trichotillomania and Traction Alopecia

      research Trichotillomania and Traction Alopecia

      May 2017 in “InTech eBooks”
      Hair pulling disorder is treated with therapy and medication; hair loss from tension can be reversed if caught early.
      Hair Loss And Its Management In Children

      research Hair Loss And Its Management In Children

      5 citations, November 2011 in “Expert Review of Dermatology”
      The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.
      Psychotrichology: Psychosomatic Aspects of Hair Diseases

      research Psychotrichology: Psychosomatic Aspects of Hair Diseases

      20 citations, November 2012 in “Journal der Deutschen Dermatologischen Gesellschaft”
      Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.